RERE vs. NNOX, FC, MKTW, ADSE, LQDT, DADA, BWMN, RDUS, ACTG, and DSP
Should you be buying ATRenew stock or one of its competitors? The main competitors of ATRenew include Nano-X Imaging (NNOX), Franklin Covey (FC), MarketWise (MKTW), ADS-TEC Energy (ADSE), Liquidity Services (LQDT), Dada Nexus (DADA), Bowman Consulting Group (BWMN), Radius Recycling (RDUS), Acacia Research (ACTG), and Viant Technology (DSP). These companies are all part of the "business services" sector.
ATRenew (NYSE:RERE) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation.
In the previous week, ATRenew had 2 more articles in the media than Nano-X Imaging. MarketBeat recorded 5 mentions for ATRenew and 3 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.92 beat ATRenew's score of 0.13 indicating that Nano-X Imaging is being referred to more favorably in the news media.
19.3% of ATRenew shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 10.7% of ATRenew shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
ATRenew has higher revenue and earnings than Nano-X Imaging. ATRenew is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.
ATRenew has a beta of -0.25, meaning that its share price is 125% less volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 2.15, meaning that its share price is 115% more volatile than the S&P 500.
Nano-X Imaging received 23 more outperform votes than ATRenew when rated by MarketBeat users. Likewise, 67.57% of users gave Nano-X Imaging an outperform vote while only 18.18% of users gave ATRenew an outperform vote.
Nano-X Imaging has a consensus price target of $16.25, indicating a potential upside of 61.21%. Given Nano-X Imaging's higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than ATRenew.
ATRenew has a net margin of -1.20% compared to Nano-X Imaging's net margin of -613.59%. ATRenew's return on equity of 2.61% beat Nano-X Imaging's return on equity.
Summary
Nano-X Imaging beats ATRenew on 9 of the 17 factors compared between the two stocks.
Get ATRenew News Delivered to You Automatically
Sign up to receive the latest news and ratings for RERE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RERE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
